Introduction
Intensive glucose control is widely practised in the ICU 1 . However, the associated frequent glucose measurements are time consuming for the nursing staff and there is no information available about glucose values in between those measurements. Occurrence of hypoglycaemia is independently associated with mortality in the ICU 2 . Continuous glucose monitoring could therefore be a step forward by decreasing severe hypoglycaemia frequency 3 and possibly by increasing time within blood glucose target range. Although we recently reported promising results of continuous glucose sensor accuracy in cardiac surgery patients 4 , a patient population that seems to benefit most from intensive insulin treatment 5;6 , other studies reported suboptimal accuracy of the commercially available systems 7;8 .
A part of the accuracy problem in critically ill patients could result from the fact that current commercially available needle-type continuous glucose sensors measure glucose concentrations in the interstitial fluid and not directly in blood. The transport of molecules such as glucose to the interstitial fluid is dependent on glucose supply to the tissue and therefore on microcirculatory function. In critically ill patients the microcirculatory function is altered 9;10 which might negatively affect sensor performance.
In this investigator-initiated study we investigated the microcirculation in patients after cardiac surgery in the ICU and assessed whether microcirculatory variables and other patient-related factors were associated with accuracy of the Guardian ® Real-Time (Medtronic Minimed, Northridge, CA) and FreeStyle Navigator ® (Abbott Diabetes Care, Alameda, CA) continuous glucose monitoring systems.
Materials and Methods

Patients
We performed a prospective observational study in a 20-bed mixed ICU in the Onze Lieve Vrouwe Gasthuis (OLVG; Amsterdam, the Netherlands). The study was approved by the Institutional Review Board. We included patients above the age of 18 who were to undergo elective cardiac surgery; coronary artery bypass grafting (CABG) and/or valve surgery. We excluded patients with an abdominal condition which would impair sensor insertion. Eligible patients received an information letter at least one week before hospital admission and were asked to give written informed consent after additional explanation of the study the day before surgery.
140
Glucose monitoring
After we obtained informed consent the two needle-type sensors (the Guardian ® RealTime, Medtronic Minimed, Northridge, CA and the FreeStyle Navigator ® , Abbott Diabetes Care, Alameda, CA) were inserted in the abdominal wall on either side of the umbilicus the day before surgery and calibrated to allow stabilization of the signal. Upon arrival at the ICU after surgery, the device's internal clock was synchronised with the bedside computer and both devices were calibrated simultaneously. Further calibrations were performed according to manufacturers' instructions. The devices were removed after 48 h of ICU admission or earlier when the patient was discharged.
During the study a reference arterial blood glucose value was measured with the AccuChek handheld glucose measurement device (Performa II, lot 320098, Roche/Hitachi ® , Basel, Switzerland) every two hours. These samples were used as calibration when needed and as reference otherwise. An in-house quality assurance study showed that the slope of the regression between this point-of-care measurement method and arterial glucose measurement by blood gas analysis was 1.0 (95% CI 1.00-1.02, n = 1,393, sample range 2.9-30.0 mmol/l; Passing-Bablok regression) and 95% of the absolute differences between reference and point-of-care measurement were lower than 15%, thereby meeting the ISO 15197 guideline 11 . All results were stored in the ICU's clinical information system (iMDsoft; MetaVision ® , Tel Aviv, Israel). Using a dynamic computerised algorithm implemented in 2001 12 , glucose values between 5.0 and 8.0 mmol/l were targeted. The nursing staff was instructed to adjust the insulin infusion rate depending on the current glucose value and the rate of glucose change based on the previous five measurements. The nurses did not act upon the sensor glucose values.
Measurement of the microcirculation
We assessed the microcirculation by recording the sublingual microcirculation, after gentle removal of excess saliva, using a handheld sidestream dark-field (SDF) camera. This method has been described in detail previously 13 . Imaging was performed as soon as possible after the patient arrived at the ICU and 2 and 4 hours thereafter, as well as at 8:00, 12:00 and 16:00 hrs the next days until the patientwas discharged from the ICU with a maximum of 48 hrs after ICU admission. At each timepoint SDF recordings of at least three different sublingual sites were recorded, stored and later scored in random order to prevent bias. During the scoring procedure recordings were excluded when there was no flow visible in the large vessels indicating a pressure artefact, presence of excess saliva making it impossible to reliably visualise all vessels, and/or excess movement of the recording. We analyzed small vessels with a diameter <20 μm in line with previous literature 14 since these capillaries and small venules are considered to be most important in nutrient, i.e. glucose, transport. Together with every SDF recording a reference plasma glucose measurement was obtained to calculate sensor accuracy.
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We scored the microvascular flow index (MFI), the proportion of perfused vessels (PPV) and the perfused vessel density (PVD) per sublingual site per patient. The three outcomes per timepoint per patient were then averaged according to the consensus statement on how to evaluate the microcirculation 15 using the automated vascular analysis (AVA) programme version 3.0 (Department of Medical Technological Development, Academic Medical Centre, and MicroVision Medical, Amsterdam, the Netherlands). In brief, for PVD and PPV the vessel density was calculated as the number of vessels crossing 3 horizontal and 3 vertical equidistant lines divided by the total length of the lines. Perfusion of the crossing vessels was scored as follows: 0 = no flow, 1 = intermittent flow (flow present <50% of the recording), 2 = sluggish flow (flow present >50% but <100% of the recording or continuous very slow flow), 3 = continuous flow. PVD was then calculated as the number of crossing vessels with flow present (scores 2 or 3) reported in n/mm. PPV is the proportion of vessels with flow present (scores 2 or 3) 9 . For the MFI the predominant type of flow in four quadrants was determined according to the same scoring system. The MFI is the sum of these flow scores divided by the number of quadrants where the vessel type is visible 16;17 . The heterogeneity index (HI) per timepoint for the PVD was calculated by dividing the difference between the lowest and the highest value by the mean to objectify intra-site differences per timepoint 18 .
The MFI was scored by two different investigators (SES and TB), compared and revised by consensus when the separate scores differed more than one point. The final score was obtained by averaging the separate scores. The PPV and PVD were scored by one investigator (SES) and intra-observer variability was determined by reanalyzing 17 randomly chosen movie sequences again after 4 weeks. The intraclass correlation coefficient (ICC) was calculated using a two-way random model to determine absolute agreement. The ICC (95% CI) for PVD was 0.94 (0.84-0.98) and for PPV 0.94 (0.84-0.98), indicating good intra-observer agreement.
Additionally, tissue oxygenation (StO2) was measured with near-infrared spectroscopy to assess microcirculatory function (InSpectra tm StO2 Tissue Oxygenation Monitor, Hutchinson Technology, Hutchinson, MN, USA). The StO2 is a measure of oxygen consumption of the tissue and a predictor of organ dysfunction 19 . It reflects the ratio of oxygenated haemoglobin to total haemoglobin in the microcirculation measured by the absorption of near infrared light (wavelength 700-1000 nm). The probe was placed on the thenar muscle at ICU arrival and removed after 48 hrs or upon discharge from the ICU.
Other variables
Besides microcirculatory variables, other factors possibly influencing CGM accuracy were obtained at the time of every reference glucose measurement: mean arterial pressure (MAP), peripheral and rectal temperature, pulse oximeter oxygen saturation and dosing of vasoactive medication. The Acute Physiology and Chronic Health Evaluation IV predicted mortality (APACHE IV PM) was calculated for the first 24 hrs of admission and the Sequential Organ Failure (SOFA) score was obtained daily. Also the European System for Cardiac Operative Risk Evaluation (euroSCORE) score, a method of calculating predicted operative mortality risk for patients undergoing cardiac surgery, was recorded for every patient.
Data interpretation and statistics
We calculated the relative absolute deviation (RAD) [|sensor value-reference glucose|/ reference glucose] between reference glucose and the next available sensor glucose value within 5 minutes to assess the real-time accuracy of the devices. To describe patient characteristics and overall circulatory function the median (IQR) or mean (SD) of the mean values per patient were calculated (Table 1 and 2) . First, associations between sensor accuracy and individual circulatory variables were assessed using a linear mixed-effects model for repeated measures. Second, we built a multivariable model for each sensor with those variables having a significant association with the accuracy of that specific sensor. Last, the microcirculatory variables (MFI, PVD, PPV and StO2) were forced in turn into the definite model to assess a possible independent effect on sensor accuracy. All analyses were performed using Predictive Analytics Software (PASW) statistics version 18.0 (SPSS Inc., Chicago, IL, USA). A P-value <0.05 was considered statistically significant.
Results
We included 61 patients in the study, of whom 1 patient dropped out due to cancellation of surgery because of intercurrent febrile illness. In total 60 patients were available for the final analysis of whom 48 were males. The median (range) age was 65 (25-85) years and 16 of the patients were previously diagnosed with type 2 diabetes. The majority of the patients underwent only a CABG procedure (53.3%). The median (IQR) euroSCORE score was 4.0 (2.0-5.0). Median (IQR) APACHE IV PM and maximum SOFA scores were 0.01 (0.003-0.02) and 6.0 (5.3-7.0). Patient characteristics are reported in Table 1 .
Microcirculation
In total, SDF recordings at 246 time points met our quality criteria for MFI assessment, Values are depicted as median (IQR) unless stated otherwise, calculated from the mean per patient during ICU admission. APACHE IV PM, Acute Physiology and Chronic Health Evaluation IV predicted mortality; CABG, coronary artery bypass grafting; euroSCORE, European System for Cardiac Operative Risk Evaluation; RAD, relative absolute deviation; SOFA max, maximum sequential organ failure assessment score per patient during the study period; Valve surgery includes mitral valve plasty, tricuspid valve plasty, aortic valve replacement or a combination of these.
ICU admission, from 88.6% (5.6) to a maximum of 91.2% (3.9) after 6 hrs, and decreased thereafter, stabilizing after 20 hrs (Figure 1 ). This increase in StO2 was accompanied with a decrease in PVD (b= -0.697, SE=0.267, p=0.01, linear mixed-effects model for repeated measures). In line with this observation we found that the PVD was lowest in the first eight hours after ICU admission compared with the next day ( 
CGM accuracy
Overall, the Navigator sensor performed significantly better than the Guardian sensor (median [IQR] RAD 11% [8] [9] [10] [11] [12] [13] [14] [15] [16] and 14% [11] [12] [13] [14] [15] [16] [17] [18] , p=0.05 4 ). Results of this head-tohead comparison are described in Chapter 9 of this thesis. In a linear mixed-effects model for repeated measures, variables that were individually associated with worse Navigator sensor accuracy were higher age, a diagnosis of diabetes, decreased peripheral temperature, increase in ketanserine, dopamine or enoximon dose and higher APACHE IV PM. Only decreased peripheral temperature and increasing dopamine use were associated with decreased accuracy of the Guardian sensor (Table 3A) . None of the microcirculation variables nor sex, MAP, norepinephrine dose and nitroglycerine dose showed significant associations with accuracy of one of the sensors.
Subsequently, we built a multivariable model per sensor with the significantly associated factors (Table 3A) . Due to co-linearity between APACHE IV PM and ketanserine dose we only included APACHE IV PM in the final model. This model showed that for the Navigator only higher APACHE IV PM (b=0.017, SE= 0.004, p<0.001), lower peripheral temperature (b= -0.008, SE= 0.003, p=0.003) and higher age (b=0.002, SE=0.001, p=0.037) remained significantly associated with an increase in sensor RAD, i.e. worse sensor accuracy. For the Guardian a decrease in peripheral temperature remained associated with an increase in RAD (b= -0.006, SE= 0.003, p=0.048). Figure 2 shows crude accuracy of both sensors stratified by peripheral temperature. Lastly, we successively forced the microcirculatory variables in these final models to assess a possible independent effect on sensor accuracy. Forcing these variables in turns did not reveal a significant association with sensor accuracy (Table 3B) . Linear mixed-effects model for repeated measures, with the different patients as subjects and the two hour reference glucose measurements as repeated measures, using the AR(1) repeated covariance structure. Sensor accuracy, i.e. relative absolute deviation was the dependent variable. Covariates were put into the model as fixed effects. A: individual associations of variables with sensor accuracy (univariate) and basic model of both sensors including the variables with individual significant association with sensor accuracy (multivariate). B: forced introduction of the microcirculatory variables in turns does not show a significant association with sensor accuracy. APACHE IV PM, acute physiology and chronic health evaluation IV predicted mortality; DM, diabetes mellitus; MFIs, microvascular flow index of small vessels; PVD, perfused vascular density; PPV, proportion of perfused vessels; SE, standard error; StO2, tissue oxygen saturation.
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Discussion
In the current study we found microcirculatory impairment to a limited extent in cardiac surgery patients in the first hours of ICU admission after surgery during a median follow-up of 23 hrs. Microcirculatory impairment was reflected by a decrease in PVD and a transient increase in StO2 but no differences in PPV and MFI. The microcirculatory variables showed no relationship with continuous glucose sensor accuracy. Variables associated with worse sensor accuracy were higher age, lower peripheral temperature and higher APACHE IV PM for the Navigator sensor and lower peripheral temperature only for the Guardian sensor.
Previous studies of microcirculatory function in postoperative cardiac surgery patients show various results. Some found normal MFI values at ICU arrival 20 and PVD one hour after cardiopulmonary bypass 21 , whereas De Backer et al. 22 found a decrease in PPV at the end of on-pump surgery persisting until 24 hrs after surgery. Of note, the latter is the only study besides the present study with more than 1 hr follow-up during postoperative ICU admission of cardiac surgery patients. Looking at the absolute values of the measured microcirculation variables, the MFI, PPV and HI found in our population are roughly comparable with healthy controls measured by Trzeciak 18 . PVD in our group was somewhat smaller than in this control group and not as low as in sepsis patients 9 . Unfortunately, we did not have the opportunity to measure microcirculatory function pre-operatively and therefore we are unable to assess pre-to postoperative changes.
We found an increase in StO2 after ICU admission with a peak after 6-12 hrs ( Figure 1 ) and a gradual decrease thereafter stabilizing to normal levels under 90% after 20 hrs of ICU stay. No studies measuring StO2 in patients after cardiac surgery are known to us. Together with the increase in StO2, the lowest PVD values were found in the first 8 hrs of ICU admission and the increase in StO2 was significantly associated with the decrease in PVD in mixed model analysis. Endotoxin release and subsequent triggering of the inflammatory response observed in on-pump surgery could explain these findings. Endotoxin levels peak shortly after surgery 23;24 and the inflammatory response, as represented by plasma IL-6 concentration, is found to be highest after 6 hrs 23 which is comparable with the observed peak in StO2. A much larger inflammatory response is seen in sepsis and this is accompanied by large microcirculatory changes 9 and also a possible increase in StO2 due to impaired oxygen offloading in a hyperdynamic flow state 25 . The changes seen in our population could thus be due to similar but much smaller changes as those seen in sepsis caused by distributive shock, due to arterial-venous shunting of the microcirculation reducing the number of perfused vessels thereby disabling oxygen offloading. This hypothesis is supported by the stable CaO2 during ICU admission (Figure 1 ) which makes it unlikely that the increased StO2 could be explained by an increase in oxygen supply.
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Microcirculatory variables did not influence accuracy of both sensors. As far as we know no previous studies assessing this relation have been performed. This finding suggests that microcirculatory status does not impair glucose transport in cardiac surgery patients; at least not to the extent that it has impact on subcutaneous sensor performance. The patients included in this study had a relatively good microcirculation as measured by MFI, PPV and PVD; although differences between patients were quite large (PVD ranged 5.9-13.8 vessels/mm). It remains to be established whether in patients with worse overall microcirculatory variables, i.e. patients with the sepsis syndrome, sensor performance is affected.
A decrease in peripheral temperature did influence the accuracy of both sensors negatively. This finding is in contrast with one other study performed in pediatric cardiac surgery patients using the older Guardian RT CGM system not showing a relationship 26 . It is however plausible that the temperature of the skin influences sensor accuracy since the optimal reaction temperature for the glucose oxidase enzyme incorporated in the sensors is 30-40 degrees Celsius 27 and skin temperature during and shortly after cardiac surgery is often below that lower limit. Nevertheless, the decreased sensor accuracy needs to be put into clinical perspective as the median (IQR) RAD of both sensors during peripheral temperatures under 31 degrees Celsius is still relatively low (Navigator: 10.5% [4.8-20 .0], Guardian: 14.7% [6.6-27.7] ; Figure 2 ).
The performance of the Navigator was also negatively influenced by higher age and higher APACHE IV PM. As we hypothesised, the highest RAD was found in the more severely ill patients, but apparently the used microcirculatory variables did not mediate this effect in those with the highest APACHE IV PM. Also APACHE IV PM in our patient group was relatively low; therefore these results cannot be extrapolated to patients with higher severity of disease scores. Notably, the accuracy of the Navigator was influenced by more variables than the accuracy of the Guardian. Possibly the inaccuracy of the Guardian is largely dependent on sensor-related factors overruling the influence of patient-related variables.
Conclusions
This study showed that in cardiac surgery patients microcirculation was impaired after surgery, reflected by a transient increase in StO2 and decrease in PVD, but was overall quite good compared with septic patients and healthy controls. The impairment in microcirculatory variables was not related to sensor accuracy but peripheral temperature (both sensors) and age as well as APACHE IV PM (Navigator) was. These results support CGM use in cardiac surgery patients characterised by low severity of illness. Further 149 studies need to assess the influence of microcirculatory changes on sensor accuracy in more severely ill patients.
